NRGene Technologies Ltd.
NRGN | TA
Overview
Corporate Details
- ISIN(s):
- IL0011720716
- LEI:
- Country:
- Israel
- Address:
- 5 Golda Meir Street, 7403649 Ness Ziona
- Website:
- https://nrgene.com/
- Sector:
- Health Care
- Industry:
- Biotechnology
Description
Nrgene offers advanced genomics and data analysis tools for agricultural research, helping improve crop yields and sustainability in Israel.
Market Data
Market Data Not Available
Last Price
Change / %
Market Cap
N/A
Volume
Day High
Day Low
52W High
52W Low
Financials & KPIs
No data available
No Financial Data Available
Standardized financial statements for the selected period are not yet available.
Filings
Chat, Summarize & Extract with AI!
You have of free filing views remaining.
Upgrade for unlimited access.
| Date | Filing | Language | Size | Actions |
|---|---|---|---|---|
| 2023-08-09 20:13 |
Regulatory News Service
Following the completion of its contracted two-year engagement under the Tel Av…
|
Hebrew (modern) | 174.5 KB | |
| 2023-08-09 20:13 |
Regulatory News Service
Following the completion of its contracted two-year engagement under the Tel Av…
|
Russian | 46.0 KB | |
| 2023-05-22 23:48 |
Business and Financial Review
Analysis update report, target price remains 19.8 NIS
|
English | 969.2 KB | |
| 2023-05-22 23:48 |
Major Shareholding Notification
Analysis update report, target price remains 19.8 NIS
|
Russian | 70.9 KB | |
| 2023-04-13 20:31 |
Regulatory News Service
Analysis update - target price t is updated to NIS 19.8
|
English | 959.3 KB | |
| 2023-04-13 20:31 |
Regulatory News Service
Analysis update - target price t is updated to NIS 19.8
|
Russian | 67.3 KB | |
| 2022-12-11 20:51 |
Regulatory News Service
Analysis update report, target price remains 30.9NIS
|
English | 1.1 MB | |
| 2022-12-11 20:51 |
Major Shareholding Notification
Analysis update report, target price remains 30.9NIS
|
Russian | 64.0 KB | |
| 2022-09-13 22:01 |
Regulatory News Service
update Analysis (FROST) following financial report, target price remains NIS 30…
|
English | 1.2 MB | |
| 2022-09-13 22:01 |
Major Shareholding Notification
update Analysis (FROST) following financial report, target price remains NIS 30…
|
Russian | 60.5 KB | |
| 2022-08-15 21:22 |
Investor Presentation
Investors Presentation - August 2022
|
English | 2.5 MB | |
| 2022-08-15 21:22 |
Company Presentation
Investors Presentation - August 2022
|
Russian | 41.9 KB | |
| 2022-05-31 21:47 |
Investor Presentation
Analysis update report, target price remains 30.9NIS
|
English | 1.1 MB | |
| 2022-05-31 21:47 |
Major Shareholding Notification
Analysis update report, target price remains 30.9NIS
|
Russian | 55.2 KB | |
| 2022-04-03 22:30 |
Business and Financial Review
Quarterly analysis update report, target price remains 30.9NIS
|
English | 1.1 MB |
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
Peer Companies
| Company | Country | Ticker | View | |
|---|---|---|---|---|
|
1NKEMIA | Spain | IKM | |
|
2cureX AB | Sweden | 2CUREX | |
|
4SC AG | Germany | VSC | |
|
Abera Bioscience AB | Sweden | ABERA | |
|
ABIONYX Pharma | France | ABNX | |
|
Abliva | Sweden | ABLI | |
|
AB Science | France | AB | |
|
Acticor Biotech | France | ALACT | |
|
Active Biotech | Sweden | ACTI | |
|
AcuCort AB | Sweden | ACUC |